NNC0165-1273 TFA reduces nocturnal food intake, attenuates feeding behavior, induces early satiety, and causes dose-dependent decreases in body weight and fat mass in diet-induced obese mice
This tiny chemical change has a big impact
The Notice of Compliance, which represents Health Canada approval, allows the manufacturer to market the drug in Canada
Relative Cautions and Risks Some situations aren't full contraindications but call for extra caution or monitoring: History of pancreatitis : There's a rare link (about 0.3% risk), so if you've had it before, alternatives might be better
Perfect for that post-semaglutide sluggishness
This might explain the common x axis intercept in LineweaverBurk plots 11,17,18 , which resemble a non-competitive inhibition pattern with identical dissociation constants for the inhibitor and substrate 52